The efficacy, safety, and cost benefit of olanzapine versus aprepitant in highly emetogenic chemotherapy: a pilot study from South India - Babu, G; Saldanha, S C; Kuntegowdanahalli Chinnagiriyappa, L (Chemother Res Pract, 2016)